New York State Common Retirement Fund’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

New York State Common Retirement Fund’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$1.32M	–	3329
2020 Q4	$1.32M	Sell	10,000 -1,400	-12%	-$124K	﹤0.01%	1906
2020 Q3	$576K	Hold	11,400	–	–	﹤0.01%	2145
2020 Q2	$543K	Hold	11,400	–	–	﹤0.01%	2163
2020 Q1	$558K	Hold	11,400	–	–	﹤0.01%	1981
2019 Q4	$654K	Hold	11,400	–	–	﹤0.01%	2157
2019 Q3	$410K	Hold	11,400	–	–	﹤0.01%	2422
2019 Q2	$354K	Buy	11,400 +6,400	+128%	+$173K	﹤0.01%	2539
2019 Q1	$117K	Hold	5,000	–	–	﹤0.01%	2912
2018 Q4	$69K	Buy	+5,000	New	+$63.1K	﹤0.01%	3050

New York State Common Retirement Fund's EIDX Position: Q1 2021 in Review

New York State Common Retirement Fund sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 10,000 shares — an estimated $1.32M sold.

New York State Common Retirement Fund first reported a position in EIDX in Q4 2018 and held it in 9 quarters. The position peaked at $1.32M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

New York State Common Retirement Fund reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 10,000 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.32M.
New York State Common Retirement Fund first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2018 and held it in 9 quarters.
New York State Common Retirement Fund's Eidos Therapeutics, Inc. Common Stock position peaked at $1.32M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on New York State Common Retirement Fund's 13F filing for Q1 2021, filed 11 May 2021.